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Summary
Osteoblasts and chondrocytes are involved in build-
ing up the vertebrate skeleton and are thought to dif-
ferentiate from a common mesenchymal precursor,
the osteo-chondroprogenitor. Although numerous
transcription factors involved in chondrocyte and os-
teoblast differentiation have been identified, little is
known about the signals controlling lineage deci-
sions of the two cell types. Here, we show by condi-
tionally deleting b-catenin in limb and head mes-
enchyme that -catenin is required for osteoblast
lineage differentiation. Osteoblast precursors lacking
b-catenin are blocked in differentiation and develop
into chondrocytes instead. In vitro experiments dem-
onstrate that this is a cell-autonomous function of
-catenin in an osteoblast precursor. Furthermore,
detailed in vivo and in vitro loss- and gain-of-function
analyses reveal that -catenin activity is necessary
and sufficient to repress the differentiation of mes-
enchymal cells into Runx2- and Sox9-positive skeletal
precursors. Thus, canonical Wnt/-catenin signaling
is essential for skeletal lineage differentiation, pre-
venting transdifferentiation of osteoblastic cells into
chondrocytes.
Introduction
The vertebrate skeleton develops during embryogen-
esis. Elements of the axial and appendicular skeleton
are formed by endochondral ossification, a process
during which mesenchymal cells condense to form a
cartilaginous template, prefiguring the future bone. This
cartilage template is eventually replaced by bone.
Some bones such as the flat bones of the skull are,
however, formed without prior formation of a cartilagi-
nous mold, whereby cells within a condensed mes-
enchymal cell layer differentiate into bone-forming*Correspondence: hartmann@imp.univie.ac.atcells, the osteoblasts, a process referred to as mem-
branous ossification. Interestingly, a similar process
takes place during endochondral bone formation in the
condensed mesenchymal layer surrounding the cartilage
template, the periosteum. The innermost periosteal
cells differentiate into osteoblasts secreting the bone
matrix (osteoid), which eventually becomes calcified,
forming the bone collar. Osteoblast differentiation in the
periosteum is coupled to chondrocyte maturation. As
chondrocytes mature, they cease to proliferate and dif-
ferentiate into prehypertrophic chondrocytes express-
ing the secreted molecule Indian hedgehog (Ihh). Ihh is
a central regulator of skeletogenesis, which among
other activities is required for osteoblastogenesis in en-
dochondral, but not membranous, bones (Kronenberg,
2003).
Osteoblastogenesis is a temporally controlled, multi-
step process, starting around E13.5 of mouse develop-
ment in both membranous and endochondral skeletal
elements. It requires sequential activity of at least two
transcription factors, Runx2/Cbfa1, a member of the
runt family, and Osterix (Osx), encoding a Zn finger tran-
scription factor of the Krüppel-like family and acting
downstream of Runx2 (Nakashima and de Crombrug-
ghe, 2003). In endochondral bones, temporal regulation
of osteoblastogenesis is achieved by two mechanisms:
Periosteal Runx2 expression is dependent on chondro-
cytic Ihh expression, coupling the onset of osteoblasto-
genesis to chondrocyte differentiation (St-Jacques et
al., 1999). Furthermore, osteogenic Runx2 activity is
suppressed through protein-protein interactions with
members of the Twist transcription factor gene family
(Bialek et al., 2004). Both transcription factors, Runx2
and Osx, are also expressed in prehypertrophic and hy-
pertrophic chondrocytes, but only Runx2 is required for
chondrogenesis (Inada et al., 1999; Kim et al., 1999; Na-
kashima et al., 2002; Yoshida et al., 2004; Zelzer et al.,
2001). Interestingly, loss of Osx results in a transforma-
tion of periosteal cells into chondrocytes (Nakashima
et al., 2002), while no such transformations are ob-
served in Runx2 mutants (Komori et al., 1997; Otto et
al., 1997). It has previously been suggested that chon-
drocytes and osteoblasts derive from a common pre-
cursor (Fang and Hall, 1997). While osteoblastic lineage
entry requires Runx2, chondrogenic lineage decision is
controlled by three members of the Sox family of tran-
scription factors, Sox9, L-Sox5, and Sox6, which are
needed in two successive steps during chondrogenesis
(Bi et al., 1999; Lefebvre et al., 2001).
Osteoblastogenesis is regulated by various secreted
factors, such as Ihh, BMPs, TGFβ, FGFs, and IGFs
(Hoffmann and Gross, 2001; Karsenty and Wagner,
2002; Marie, 2003). Canonical Wnt/β-catenin signaling
has recently been implicated in osteoblastogenesis
(Bain et al., 2003; Bodine et al., 2004; Gong et al., 2001;
Hartmann and Tabin, 2000; Kato et al., 2002; Rawadi et
al., 2003). Wnts activate the canonical pathway through
interaction with their receptors of the Frizzled family
and coreceptors of the LRP5/6 family. This interaction
stabilizes β-catenin levels and affects its subcellular lo-
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728calization. Gain-of-function experiments in chicken first t
hhinted at a potential role for canonical Wnt signaling in
chondrocyte maturation and osteoblastogenesis (Hart- d
pmann and Tabin, 2000). More direct evidence for in-
volvement of canonical Wnt signaling in osteoblasto- l
sgenesis came from the finding that loss-of-function
mutations in the Lrp5 gene, encoding a coreceptor of d
ocanonical Wnt signaling (Mao et al., 2001), result in a
decrease in bone density associated with defects in os- n
wteoblast differentiation and proliferation (Gong et al.,
2001; Kato et al., 2002), while Lrp5 gain-of-function mu- b
btations are associated with an increase in bone mass
(Johnson et al., 2004). b
tMost of the observations implicating canonical Wnt
signaling in osteoblastogenesis are based on postnatal d
changes in bone density and on cell culture data; how-
ever, until recently, it was not known whether canonical w
(Wnt signaling is required for osteoblast differentiation
during embryogenesis. To address this issue, we de- b
sleted b-catenin early in embryonic development in the
limb and head mesenchyme by using the Prx1-Cre line r
c(Logan et al., 2002) and analyzed the effects on skeletal
development. A similar study with the Dermo-Cre line 2
d(a Twist2 knockin allele) was published by Hu et al.
(2005) while this study was submitted. Our analyses m
sshowed that loss of mesenchymal β-catenin resulted in
an early osteoblast differentiation arrest. No mineral- e
cized bone collar was formed, and no mature osteo-
blasts were present in endochondral and membranous f
(bones. Molecular marker analyses revealed that osteo-
blastogenesis was arrested in long bones of conditional i
ab-catenin mutants at the level of an osteo-chondro-
genic progenitor cell and that these cells differentiated o
finto chondrocytes. In vitro data further showed that
β-catenin was required in a cell-autonomous manner, t
acting either downstream or in parallel to Ihh and BMP
signaling in osteoblastogenesis. Furthermore, we showed A
by using loss- and gain-of-function alleles that β-catenin o
activity is required early in skeletogenesis to repress H
differentiation of mesenchymal cells into the chondro- r
cyte lineage. Based on these findings, we propose that t
canonical Wnt/β-catenin signaling controls a molecular s
switch that regulates lineage commitment between c
chondrocytes and osteoblasts. i
t
fResults
t
wEarly Inactivation of -Catenin in Limb and Head
Mesenchyme Affects Skeletogenesis 2
nWe first examined in which skeletal cells β-catenin pro-
tein accumulated by immunohistochemistry. Cells of p
ethe joint region, prehypertrophic chondrocytes and
periosteal cells, stained more intensely and showed b
nuclear distribution of β-catenin, suggesting a role for
canonical Wnt signaling in these cells (Figures 1A–1A$; d
Isee also Guo et al., 2004). In order to address the roles
of canonical Wnt/β-catenin signaling in skeletogenesis, u
lwe used a conditional approach, deleting β-catenin ac-
tivity in limb and head mesenchyme by using the Prx1- c
HCre line (hereafter referred to as b-catPrx/−) (Logan et
al., 2002). Using a ZAP reporter line, we reinvestigated s
cPrx1-Cre activity (Figures 1B–1D and 1E#), which
amounted to patchy activity in the forelimb region at nhe 15-somite stage (data not shown) and at E9.5 in the
ead mesenchyme (Figure 1B). At E11.0, activity was
etected throughout mid- and hindbrain and was
atchy in the posterior forebrain region (Figure 1C). De-
etion efficiency in the limb was examined by RNA in
itu hybridization (ISH) by using a probe specific for the
eleted exons; almost complete b-catenin deletion was
bserved in the forelimb mesenchyme at E10.5 (data
ot shown) and in the hindlimb at E11.0 (Figure 1E#),
hile the ectoderm and cells, which are probably myo-
lasts migrating in from the somites, still expressed
-catenin. b-catPrx/− mutant embryos survived up to
irth; however, newborns died of suffocation because
hey had an open rib cage, since Prx1-Cre was also
eleting in the sternum anlage (data not shown).
Skeletal preparations of newborn mutants stained
ith alcian blue (chondrocyte matrix) and alizarin red
mineralization) revealed that the appendicular long
ones were shortened, partially fused, and lacked
ome distal structures (Figure 2A). Chondrocyte matu-
ation was affected in b-catPrx/− mutants, a finding
onsistent with previous observations (Akiyama et al.,
004), and was reflected by lack of mineralization in
istal skeletal elements (tibia, fibula, and tarsal ele-
ents) in the hindlimb (Figure 2B). Proximal elements
uch as the pubis, ischium, ilium, and femur were min-
ralized (Figure 2B). The forelimb was more dramati-
ally affected than the hindlimb, corresponding to dif-
erential onset of Prx1-Cre activity in fore- and hindlimb
Logan et al., 2002). In the skull, loss of β-catenin activ-
ty resulted primarily in a loss of calvarial bones such
s interparietale and parietale, while frontal bones were
nly partially affected, and nasal bones were not af-
ected at all (Figure 2C). These findings correlate with
he pattern of Prx1-Cre activity.
rrest of Osteoblast Differentiation upon Loss
f -Catenin in Limb Mesenchyme
istological analyses of the femur of newborn mutants
evealed a similar overall growth plate organization to
hat of wild-type; however, the hypertrophic region was
lightly expanded (Figure 2D). Importantly, hypertrophic
hondrocytes mineralized and were degraded, result-
ng in accumulation of their mineralized matrix, al-
hough no trabecular bone and no bone collar were
ormed (Figure 2E). A true periosteum was not present;
he perichondrium instead was thickened and had a
edge-shape-like appearance in the diaphysis (Figures
D and 2E). Despite the absence of a bone collar, multi-
ucleated tartrate-resistant acidic phosphatase (TRAP)-
ositive osteoclasts, red blood cells, and hematopoi-
tic cells were still present in the maturation zone
etween the hypertrophic regions (Figures 2F and 2G).
Expression of several marker genes involved in chon-
rogenesis and osteoblastogenesis was analyzed by
SH to investigate why no bone collar was formed (Fig-
re 3). In the mutants, Ihh was expressed at normal
evels in prehypertrophic and hypertrophic chondro-
ytes from E12.5 to E18.5 (Figure 3A; data not shown).
owever, from E13.5 onward, the Ihh domain was
maller compared to wild-type, reflecting a delay in
hondrocyte maturation (Figure 3A). Ihh signaling was
ot affected, since Ptc-1 was expressed normally in
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729Figure 1. Endogenous β-Catenin Expression
in Skeletal Tissue and Prx1-Cre Activity
(A–A$) Immunohistochemical staining show-
ing higher levels of β-catenin protein in cells
of the (A) periarticular region of the joint, in
the (A# and star in A$) nucleus of flattened
proliferating and prehypertrophic chondro-
cytes, and in the (A$) periosteum at E13.5.
(B and C) Alkaline phosphatase staining of
ZAP-reporter/Prx1-Cre embryos at (B) E9.5
and (C) E11.
(D) Coronal section through the head at the
level of the white line shown in (C).
(E and E#) In situ hybridization showing
b-catenin expression in a (E) wild-type hind-
limb and in a (E#) β-catPrx/− hindlimb at
E11.5. Arrows indicate the expression in
cells that are probably migrating myoblasts.chondrocytes and the perichondrium (Figure 3D), as
was Gli-1 (data not shown). Onset of Collagen 10a1
(Col10a1) expression at E13.5 was normal (data not
shown), and so was Runx2 (Figure 3B). However, at
earlier stages (E10.5–E12.5), Runx2 expression was
upregulated, and its expression domain was expanded
(see Figure 6; data not shown); from E16.5 onward, it
was slightly downregulated in the perichondrium/peri-
osteum (Figure 3E). Twist1, which negatively regulates
Runx2 activity (Bialek et al., 2004) and is regulated by
Wnt/β-catenin signaling in other systems (Borchers et
al., 2001; Howe et al., 2003), was downregulated in the
mutant like in the wild-type around E14.5 (data not
shown). Osx was, however, not expressed in the pre-
sumptive mutant bone collar at E13.5–E18.5, while it
was still expressed in prehypertrophic and hypertro-
phic chondrocytes (Figures 3C and 3F). Collagen 1a1
(Col1a1) was expressed in the presumptive bone collar,
but at significantly lower levels compared to wild-type
(Figure 3H). Expression of Osteocalcin (Osc), a marker
gene for mature osteoblasts, could not be detected
(Figure 3I). Tcf-1, which is normally expressed in osteo-
blasts, was also not expressed in the mutant perichon-
drium/periosteum (Figure 3G). This analysis suggests
that the early steps of osteoblastogenesis are unaf-
fected, Ihh signaling can occur, and Runx2 expression
is initiated; however, osteoblastogenesis is blocked
since periosteal cells did not express Osx and did not
upregulate Col1a1 expression. Furthermore, Osc-posi-
tive osteoblasts did not develop in b-catPrx/− mutant
limbs.
Defects in Osteoblastogenesis of -Catenin Mutants
Are Not Rescued by Addition of Exogenous
Hh and BMP2
Ihh expression was initiated normally in b-catenin mu-
tants, but due to the delay in chondrocyte maturation,
fewer cells expressed Ihh. Therefore, we established a
primary cell culture system with dissociated humeri andfemora from heterozygous and mutant E13.5 embryos
to examine whether addition of exogenous recombi-
nant Hh protein can rescue the osteoblast defect. Cul-
tures from heterozygous humeri or femora upregulated
osteogenic markers and formed mineralized nodules
under differentiation conditions (Figure 3J), while those
from mutant humeri or femora did not (Figure 3J). In-
stead, mutant cultures expressed the chondrogenic
marker Collagen 2a1 (Col2a1) continuously at high
levels (real-time PCR analysis, data not shown). Addi-
tion of recombinant Shh or BMP2 protein or of both
proteins together increased expression of osteogenic
markers, such as Osc, Alkaline phosphatase (ALP), and
Bone sialoprotein II (Bsp), and the mineralization poten-
tial of heterozygous cultures (Figures 3J and 3K; data
not shown). In contrast, these markers were only
slightly upregulated in response to exogenous factors
in mutant cultures, and addition of either recombinant
Shh or BMP2 protein or addition of both proteins to-
gether did not rescue the mineralization defect (Figures
3J and 3K; data not shown). This suggests that β-cat-
enin is required either downstream of Ihh and Bmp sig-
naling in osteoblast differentiation, or that it provides
an essential independent signal for osteoblastogen-
esis.
Periosteal Cells Differentiate into Chondrocytes
in the Absence of -Catenin
Instead of the normal bone collar, the perichondrium/
periosteum of long bones of b-catPrx/− mutant new-
borns had a wedge-shaped appearance, within which
round-shaped cells were visible (Figure 4A). These
round-shaped cells were embedded in a matrix, which
stained positive for alcian blue (Figure 4A#) and ex-
pressed chondrogenic markers such as Sox9 and
Col2a1 (Figures 4B and 4C). In contrast, markers for
differentiated chondrocytes, such as Ihh and Col10a1,
were only expressed in their normal domains within the
cartilage element and in cells lining the perichondrial
Developmental Cell
730Figure 2. Skeletal Alterations in β-Catenin Mutant Animals at Late Stages of Development
(A–C) Skeletal preparations of wild-type (WT) and b-catPrx/− (Prx/−) mutant P0 embryos showing the whole skeleton, the hindlimbs, and the
head skeleton.
(D–G) Wild-type and mutant femurs at PO. (D) Hematoxylin/eosin staining. (E) Van Kossa staining of bone collar in the wild-type (arrow), which
is absent (star) in the mutant. (F) TRAP staining, demonstrating that multinucleated osteoclasts (inlet) are present in the mutant. High-
magnification (20×) hematoxylin/eosin-stained sections, showing that eosin-positive red blood cells and hematopoietic cells are present (E).edge, but not in cells within the perichondrial wedge (
w(Figures 4D and 4E). These data suggest that canonical
Wnt/β-catenin signaling is required to repress the chon-
idrogenic potential of osteo-chondroprogenitors lo-
cated within the periosteum. p
β
i-Catenin Is also Required for Osteoblastogenesis
cof Membranous Bones
wNo ossification was detected in the region of the mem-
(branous parietale and interparietale bones of b-catenin
cmutants at birth; instead, a lace-work pattern of ectopic
ucartilage, which stained positive for alcian blue, was
fobserved (Figure 2C). Coronal sections through the
sskull confirmed that no mineralized bone was formed,
cand that most of the mesenchyme instead developed
3into chondrocytes (Figure 5A), leading to a dorsal ex-
ipansion of the cartilaginous base. When we analyzed
scoronal sections through the skull by ISH at E12.5–
pE16.5 for expression of chondrogenic and osteogenic
5markers, Sox9 and Col2a1 expression were expanded
Adorsally (Figures 5B and 5C). While Runx2 was still ex-
cpressed in the mutants, no Osx or Osc expression was
adetected (Figures 5D and 5E; data not shown).
cThe Prx1-Cre line is potentially also active in the head
cectoderm and dura mater (Figure 1C). The latter isknown to secrete factors affecting osteoblastogenesisKim et al., 1998; Rice et al., 2000; Spector et al., 2002),
hich complicates the phenotypic interpretation.
To unambiguously demonstrate that β-catenin activ-
ty is required cell-autonomously in mesenchymal
recursors for osteoblast differentiation, we deleted
-catenin activity by using an Adeno-Cre virus (AdCre)
n embryonic osteoblast cultures from b-catenin fl/fl
alvariae at E16.5. After 5 days in culture, cells treated
ith AdCre differed morphologically from the controls
data not shown). After 15 days cells started to form
ondensations resembling chondrocyte nodules (Fig-
re 5Fa), while in the controls (either untreated or in-
ected with an Adeno virus expressing EGFP, AdGfp),
ingle or sometimes clustered, small, round, refractive
ells appeared on top of a fibroblastic monolayer. After
weeks, alcian blue-positive cartilage nodules formed
n AdCre cultures (average 3–4 big and numerous
maller nodules per well), while only one alcian blue-
ositive nodule was found in the controls (n = 20; Figure
Fb). Many more cells expressed Col2a1 and Sox9 in
dCre cultures (Figures 5Fc and 5Fd), compared to the
ontrols. In contrast, Col1a1 was expressed throughout
t low levels in AdCre cultures and at high levels in the
ontrols (Figure 5Fe). However, Osc-expressing cells
ould still be detected by ISH, which is due in completedeletion (approximately 80%–90% efficiency by South-
Role of β-Catenin in Skeletal Lineage Decision
731Figure 3. Absence of Mature Osteoblast Markers in β-Catenin Mutant Limbs and Mineralization Defects of Femora Cultures
(A–I) Nonradioactive section in situ hybridizations on wild-type and b-catPrx/− (Prx/−) mutant femora at (A–C) E14.5, (D–G) E16.5, and (H
and I) E18.5, showing expression of (A) Ihh, (B and E) Runx2, (C and F) Osx, (D) Ptc-1, (G) Tcf-1, (H) Col1a1, and (I) Osc. Note that the folds
within the skeletal elements are due to sectioning and do not reflect increased expression.
(J) Alizarin red-stained mineralization assay of cultures from β-catenin heterozygous and mutant Prx/− femora at days (d) 15 and 21 of
differentiation, without (w/o) addition of exogenous factors and in the presence of exogenous recombinant Shh and BMP2 protein; this panel
shows decreased mineralization potential of mutant cultures.
(K) Relative expression of Osteocalcin (Osc), Alkaline phosphatase (ALP), and bone sialoprotein (Bsp) in heterozygous (blue) and mutant
cultures (red) at day 6, without the addition of factors (solid bars) and with the addition of Shh and BMP2 (stippled bars). Error bars represent
the standard deviation of the mean of the results (n = 3).ern blot analysis; data not shown). Concomitantly, the
cultures showed less mineralization when stained with
alizarin red (data not shown). Upregulation of Sox9 and
Col2a1 and downregulation of Col1a1 were confirmed
by real-time PCR analysis (Figure 5G). Thus, in vitro de-
letion of b-catenin in primary osteoblast cultures dem-
onstrates that β-catenin activity is cell-autonomously
required in osteoblast precursors to suppress chondro-
genesis. Calvarial cultures contain a heterogeneous
population of osteoblast precursors. Nevertheless, we
would propose that β-catenin is required in the pos-
tulated bipotential osteo-chondroprogenitor.
Activation of -Catenin also Affects Skeletogenesis
We next analyzed whether active canonical Wnt/β-
catenin signaling is able to positively regulate osteo-
blastogenesis and therefore employed mice carrying a
conditional b-catenin allele (ex3), which, upon Cre re-
combination, produces a stabilized form of β-catenin
(Harada et al., 1999). Embryos expressing stabilized
β-catenin under the control of Prx1-Cre (b-catex3Prx/+)
survived up to birth. Surprisingly, their limbs contained
only tiny remnants of skeletal elements (Figure S1A; seethe Supplemental Data available with this article on-
line). Similar to the loss-of-function situation, gain-of-
function mutant hindlimbs are less affected than the
forelimbs, which was particularly apparent by looking
at the distal digit-like structures (Figure S1B). Histologi-
cal analyses of E16.5 limbs showed that proximal cells
have an undifferentiated appearance and only distal re-
gions displayed signs of differentiation (Figure S1D). In-
terestingly, stabilization of β-catenin in the early head
mesenchyme also resulted in a loss of skull bones (Fig-
ure S1C). Thus, stabilization of β-catenin did not result
in a differentiation of mesenchymal cells into more os-
teoblasts, neither in long bones nor in calvarial bones.
On the contrary, the phenotype suggests that activation
of β-catenin negatively affects skeletogenesis.
Lineage Decision of Mesenchymal Cells Appears
to Be Controlled by -Catenin Levels
We next investigated why skeletogenesis was affected
in b-catex3Prx/+ mutants. In early b-catex3Prx/+ limbs,
Sox9 expression was almost completely lost; only a few
cell clusters still expressed Sox9 (Figures 6B and 6F).
These Sox9-positive cells are probably responsible for
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Figure 4. Differentiation of Perichondrial/Periosteal Cells into Chon- n
drocytes in b-Catenin Mutants
c
(A–C) Sections through wild-type and b-catPrx/− (Prx/−) mutant βfemora at E18.5 stained with van Kossa/alcian blue at low magnifi-
ecation. High magnification showing alcian blue-positive cells within
ethe mutant perichondrium/periosteum (arrow in [A#]), which ex-
press Col2a1 (arrow in [B]) and Sox9 (arrow in [C]). p
(D–F) (D) Ihh and (E) Col10a1 are only expressed in cells along the i
wedge-shaped mutant perichondrium, which can be also seen in w
the (F) hematoxylin/eosin-stained section. Col2a1, Sox9, Ihh, and β
Col10a1 expression are visualized by in situ hybridization.
a
s
(the formation of the skeletal remnants (see Figure S1).
Immunohistochemical analyses revealed that in a few f
ocell clusters β-catenin levels were not increased (Figure
6G), roughly corresponding to the position of Sox9- c
positive cells on adjacent sections. Interestingly, earlyn limb development, endogenous β-catenin levels were
owest in the condensed precartilaginous regions, while
he surrounding mesenchyme expressed higher levels
Figure 6C). Thus, these data suggest that high levels
f β-catenin repress expression of Sox9, a factor
ssential for chondrogenesis, thereby preventing mes-
nchymal cells from differentiating into skeletal pre-
ursors.
On the contrary, in limbs where b-catenin was de-
eted, the normally centrally restricted Sox9 domain ex-
anded throughout fore- and hindlimb mesenchyme all
he way from the dorsal to the ventral ectoderm (Figure
I; data not shown). A similar expansion was also ob-
erved for Col2a1, Sox5, and Sox6 in mutant limbs
data not shown). Surprisingly, Runx2 expression was
lso upregulated and expanded in b-catenin mutant
imbs (Figure 6J). These observations further support
he hypothesis that b-catenin signaling in the mes-
nchyme normally represses the differentiation of mes-
nchymal cells into skeletal precursors.
-Catenin Levels Control the Expression of Skeletal
ineage Markers Sox9 and Runx2
n vivo analyses of early limb buds suggested that the
evels of β-catenin activity are crucial for differentiation
f mesenchymal cells into skeletal progenitors. Using
he micromass culture in vitro system, we investigated
he temporal profile of Sox9 and Runx2 expression
hanges in response to alterations of β-catenin levels,
tilizing the two conditional alleles and the AdCre virus.
eduction in total β-catenin levels was detected in fl/
l-AdCre cultures after 24 hr by Western blot (Figure
A). Concomitantly, when we examined Sox9 expres-
ion levels by real-time PCR, Sox9 was significantly
pregulated in fl/fl-AdCre cultures 36 hr after culture
tart (Figure 7B; p < 0.05). Analogous to the in vivo situ-
tion, Runx2 was also upregulated by real-time PCR
n fl/fl-AdCre cultures (Figure 7F). Consistent with the
pregulation of Sox9 in vitro, we observed that fl/fl-
dCre micromass cultures showed precocious differen-
iation of alcian blue-positive cartilage nodules at day
compared to control AdGfp-treated cultures (Figure
C). Interestingly, this premature differentiation could
till be further enhanced by addition of recombinant
MP4 protein (Figure 7C). In contrast, when we per-
ormed micromass experiments with limbs from homo-
ygous ex3fl embryos and deleted with AdCre, stabili-
ation of β-catenin suppressed chondrogenesis (data
ot shown). Western blot analysis of ex3fl/ex3fl-AdCre
ultures revealed significant amounts of truncated
-catenin protein (Nβ-cat) after 10 hr (Figure 7D). Sox9
xpression levels were significantly downregulated in
x3fl/ex3fl-AdCre cultures as early as 12 hr (Figure 7E;
< 0.05). Runx2 expression was also downregulation
n ex3fl/ex3fl-AdCre cultures (Figure 7F). Tcf1 and Lef1,
hich have been shown to be targets of the Wnt/
-catenin pathway (Hovanes et al., 2001; Kengaku et
l., 1998; Roose and Clevers, 1999), behaved the oppo-
ite and were upregulated in ex3fl/ex3fl-AdCre cultures
Figure 7G; data not shown). Our in vitro analysis con-
irmed the in vivo observations in early loss- and gain-
f-function limb buds. It further showed that there is a
lear correlation between reduction of β-catenin proteinlevels and upregulation of Sox9 starting at 24 hr and an
Role of β-Catenin in Skeletal Lineage Decision
733Figure 5. Loss of β-Catenin in Skull Mesenchyme and Calvarial Osteoblast Progenitors Leads to Ectopic Cartilage Formation
(A) Coronal sections through the skull of wild-type and b-catPrx/− (Prx/−) mutants at P0 stained with van Kossa alcian blue (blue), showing
the presence of mineralized bone (arrow) in the wild-type, which is absent in the mutant and replaced by ectopic cartilage.
(B–D) In situ hybridizations on coronal sections showing a dorsal expansion of chondrogenic markers (B) Sox 9 and (C) Col2 in the mutants
(see arrows) at E13.5 and (D) loss of Osx expression at E16.5.
(E) Whole-mount in situ hybridizations on E16.5 wild-type and b-catPrx/− mutant heads, showing lack of Osc expression (arrow) in the
mutant skull.
(F) Primary osteoblast cultures from b-catenin fl/fl E16.5 calvariae treated with AdGfp (left panel) and AdCre (right panel) showing different
morphology at (Fa) day 15 and formation of alcian blue-positive nodules at (Fb) day 21. In situ hybridization for (Fc) Col2a1, (Fd) Sox9, and
(Fe) Col1a1.
(G) Relative expression levels of chondrogenic markers Sox9 and Col2a1 and of the marker Col1a1 at days 5, 10, and 15 of culture, analyzed
by real-time PCR. Error bars represent the standard deviation of the mean of the results (n = 2).early response between the appearances of stabilized,
truncated β-catenin and downregulation of Sox9 and
Runx2 within 2–4 hr.
Discussion
Earlier studies have implicated a role for canonical Wnt/
β-catenin signaling in chondrogenesis (Akiyama et al.,2002; Hartmann and Tabin, 2001; Ryu et al., 2002), and
the characterization of the Lrp5 mutant mice suggested
that canonical Wnt signaling is required for osteoblast
function and/or proliferation of a preosteoblast progen-
itor cell (Gong et al., 2001; Kato et al., 2002). Cell culture
studies implied that β-catenin is required downstream
of Bmp2 for osteoblast mineralization (Rawadi et al.,
2003). By genetically removing b-catenin in the early
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734Figure 6. Alterations of Prechondrogenic
Marker Expression in b-Catenin Gain- and
Loss-of-Function Mutant Limb Buds
(A–J) Transverse sections through the fore-
limb of (A–D) wild-type, (E–G) b-catenin gain-
of-function (ex3Prx/+) mutants, and (H–J)
b-catenin loss-of-function (Prx/−) mutants
at E11.0. (A) Hematoxylin/eosin staining vis-
ualizing the condensed mesenchyme in the
core of a wild-type limb. (B) In situ hybrid-
ization showing Sox9 expression in the
condensed core. (C) Immunohistochemical
staining showing higher levels of β-catenin
protein in the mesenchyme underneath the
ectoderm, and lower levels in the central
core. (D) In situ hybridization showing Runx2
expression in the scapula region. (E) No con-
densation is visible in β-catex3Prx/+ mutant
limb buds. (F) Sox9 expression is downregu-
lated in β-catex3Prx/+ mutant limbs. (G) Ec-
topic stabilization of β-catenin protein in
β-catex3Prx/+ limbs. Mosaic activity of the
Prx1-Cre line is reflected by the presence of
a few clusters of cells, which do not show
ectopic stabilization of β-catenin. (H) No
condensation is visible in β-catPrx/− mu-
tants, and (I) Sox9 expression is expanded in
the distal half of the limb bud. (J) Expanded
expression of Runx2 in β-catPrx/− mutant
limb bud.limb and head mesenchyme by employing the Prx1-Cre l
line, we showed that β-catenin activity is required at an o
early step during osteoblast lineage differentiation. No t
cortical bone and no bone trabeculae were formed c
through either intermembranous or endochondral ossi- c
fication in the absence of b-catenin. Stabilization of 2
β-catenin, however, does not lead to an increase of os- s
teoblasts, but it rather inhibits mesenchymal cells to f
enter the prechondro-osteoblast lineage, blocking skel- u
etal development at an earlier time point. h
e
r-Catenin Is Required to Suppress Chondrogenesis
Sin Mesenchymal Cells
Various Wnts signaling through the canonical pathway
ucan suppress chondrocyte differentiation in vitro (Church
eet al., 2002; Guo et al., 2004; Rudnicki and Brown, 1997;
dRyu et al., 2002); however, there are also conflicting
edata suggesting that canonical Wnt signaling enhances
cchondrogenesis (Fischer et al., 2002). Here, we provide
cin vivo evidence that β-catenin is involved in repressing
lskeletogenesis within the limb bud mesenchyme, prob-
tably utilizing Tcf1 or Lef1 as cofactors. Wnts secreted
pby the ectoderm and signaling through the β-catenin
wpathway are likely to act as chondrogenic repressors;
lhowever, since β-catenin can also be stabilized by
tother mechanisms, it is plausible that some of the ef-
Sfects observed could be due to Wnt-independent activ-
yities of β-catenin (Haq et al., 2003; Monga et al., 2002).
SInterestingly, β-catenin is described as a coactivator for
βTCF/LEF family members (Nusse, 1999), and previous
studies have suggested that Sox9 is positively regu- pated by a β-catenin/TCF transcriptional complex in
ther cells (Blache et al., 2004; Willert et al., 2002). Al-
hough the Sox9 upstream region contains three non-
anonical TCF binding sites within 2.6 kb, which are
onserved in chicken, mouse, and human (Blache et al.,
004; unpublished data), it is conceivable that β-catenin
ignaling controls the expression of a transcription
actor repressing Sox9. Given that Runx2 is also upreg-
lated early in b-catenin mutants, we currently favor the
ypothesis that β-catenin represses entry of mes-
nchymal cells into the skeletal lineage by a more gene-
al mechanism, not necessarily by directly regulating
ox9 and Runx2 expression.
Limb bud cells in which b-catenin has been deleted
pregulate Sox9, Runx2, and other chondrogenic mark-
rs; however, despite this upregulation, not every cell
ifferentiated into a chondrocyte, suggesting that β-cat-
nin downregulation is necessary but not sufficient for
hondrogenic lineage commitment. On the contrary, all
ells in which β-catenin has been stabilized downregu-
ated Sox9 and Runx2 and hence might loose their po-
ential to even differentiate into a pre-osteo-chondro-
rogenitor. In the case of the limb, this is consistent
ith the absence of Runx2 in Sox9Prx1/Prx1 mutant
imbs (Akiyama et al., 2002). However, conditional dele-
ion of Sox9 in cranial neural crest cells suggests that
ox9 is not required for membranous bones (Mori-Aki-
ama et al., 2003), ruling out the possibility that loss of
ox9 is the primary defect in the skull. Stabilization of
-catenin altered gene expression at an earlier time
oint than loss of β-catenin, and previous experiments
Role of β-Catenin in Skeletal Lineage Decision
735Figure 7. Alteration of β-Catenin Levels in Micromass Cultures Affects Sox9 and Runx2 Expression Levels
(A) Western blot showing reduction of β-catenin levels in AdCre-treated cultures from 24 hr onward.
(B) Time course of real-time PCR analysis showing upregulation of Sox9 starting at 24 hr in AdCre-treated b-catenin fl/fl cultures (n = 2).
(C) Alcian blue-stained micromass cultures at days 4 and 6 from β-catenin fl/fl limbs infected with AdenoGfp or AdenoCre virus with and
without (w/o) addition of rhBmp4, showing accelerated cartilage nodule formation upon deletion of b-catenin.
(D) Western blot showing the appearance of the N-terminal-deleted β-catenin in ex3fl/ex3fl AdCre-treated cultures at 10 hr.
(E) Real-time PCR analysis showing downregulation of Sox9 from 10 hr onward in AdCre-treated b-catenin ex3fl/ex3fl cultures (n = 3).
(F) Real-time PCR analysis showing relative expression levels of Runx2 at 14 hr going up in AdCre-treated b-catenin fl/fl cultures and going
down in AdCre-treated b-catenin ex3fl/ex3fl cultures. Error bars represent the standard deviation of the mean of the results (n = 3).
(G) Semiquantitative RT-PCR analysis of Lef-1 expression, showing an upregulation of Lef-1 in AdCre-treated b-catenin ex3fl/ex3fl at 14 hr
of culturing.have shown that stabilization of β-catenin can dediffer-
entiate or transform differentiated cell types (Bierie et
al., 2003; Miyoshi et al., 2002; Ryu et al., 2002). Further-
more, we have observed that, in addition to the loss of
skeletal marker gene expression, β-catex3Prx/+ mes-
enchymal limb bud cells had an undifferentiated ap-
pearance and upregulated a number of other genes
(data not shown), which could affect the potential of
cells to differentiate into pre-osteo-chondroprogenitors
in the limb and head mesenchyme.
-Catenin Is Essential for Osteoblast Differentiation
In the limb, early osteoblast differentiation seems to be
unaffected in b-catenin mutants, but it failed at the
commitment step lacking Osx expression. This results
are similar to those recently published by Hu et al.
(2005). Similar to the Osx mutants (Nakashima et al.,
2002), cells within the b-catenin mutant perichondrium/periosteum developed into chondrocytes. This could
either be due to the lack of Osx or to the lack of both
Osx and β-catenin. There is also the possibility that
β-catenin activity might be reduced in the Osx mutant,
which remains to be tested. Membranous bone forma-
tion was also affected by deletion of b-catenin, reveal-
ing that β-catenin is a factor generally required for os-
teoblast development. However, unlike the situation in
the limb, which resembles the Osx mutant phenotype,
the skull of b-catenin mutants is partially cartilaginous.
Ihh expression is expanded in Osx mutant skulls; never-
theless, no ectopic cartilage formation has been reported
(Nakashima et al., 2002). In the head mesenchyme,
β-catenin is probably required in a cell-autonomous man-
ner to repress the chondrogenic potential of osteo-chon-
droprogenitors, since upon in vitro deletion of β-catenin,
most cells, but not all cells, differentiate into chondro-
cytes.
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736eAt present, it is unclear which Wnt(s) is (are) serving
oas the signal(s) in this process, since none of the Wnt
cknockout mice shows a similar differentiation and ar-
f
rest in osteoblastogenesis. It is likely that various Wnts b
could act redundantly in this process given that multi- c
ple Wnt molecules (Wnt1, 3a, 4, 7a, 8c, 9a, and 9b) have
the potential to suppress chondrogenesis in vitro (Guo S
Eet al., 2004; Hartmann and Tabin, 2001; Rudnicki and
aBrown, 1997; Stott et al., 1999). In Wnt9a mutant skulls,
awe have observed the appearance of ectopic cartilage
t
islands within the parietale bone and some sutures;
however, no such differentiation was observed in the A
periosteum of long bones despite the fact that Wnt9a E
4is expressed there (unpublished data). Future double
imutant analyses might provide further inside into the
wWnt molecules involved in osteoblast lineage differenti-
mation.
(
s
eRole of -Catenin Levels in Chondrocyte
Eand Osteoblast Differentiation
wOur experiments suggest the following role for Wnt/
tβ-catenin signaling in chondrocyte and osteoblast lin-
b
eage differentiation in endochondral skeletal elements. w
A subset of mesenchymal cells is specified by sur-
rounding signals to become skeletal precursors. Within P
Fthis population, cells with low β-catenin activity can en-
dter the chondrocyte lineage, while part of the skeletal
bprecursors independent of β-catenin levels can be-
scome osteo-chondroprogenitors. However, Runx2-
i
expressing osteo-chondroprogenitors are still bipoten- (
tial and require high levels of β-catenin to suppress a
atheir chondrogenic potential and to express Osx. Upon
sOsx expression, precursors become committed to the
osteoblast lineage. Canonical Wnt/β-catenin signaling
lis likely to play additional roles during later stages of
m
osteoblastogenesis, based on the Lrp5 mutant pheno- a
type (Gong et al., 2001; Kato et al., 2002), the effects t
aseen in cell culture experiments (Bain et al., 2003; Mba-
1laviele et al., 2005; Rawadi et al., 2003), and data ob-
wtained by deleting β-catenin activity in differentiated os-
iteoblastic cells (Glass et al., 2005).
e
Differentiation of periosteal cells into chondrocytes a
can be observed during normal vertebrate skeleton de- A
ivelopment (Buxton et al., 2003). This process is also
pvery important for the formation of a cartilaginous cal-
9lus during fracture healing of endochondral and mem-
wbranous bones bridging the gap at the fracture site
i
(McKibbin, 1978). It remains to be seen whether these f
processes involve local downregulation of β-catenin m
activity. Activation of canonical Wnt signaling, by stabi-
hlization of β-catenin or LiCl treatment, has been sug-
0gested to be beneficial for increasing bone mass (Bain
3et al., 2003; Gong et al., 2001); however, in the light of
p
this study, it remains to be tested whether LiCl treat- s
ment or drug-stimulated activation of β-catenin signal- h
ing might interfere with the fracture healing process.
a
FExperimental Procedures
(
Mouse Mutants
Conditional β-catenin loss-of-function mutant mice (b-catPrx1/−) S
Fwere generated by intercrossing males double heterozygous for a
LacZ knockin null allele (Huelsken et al., 2000) and the Prx1-Cre d
2transgenic allele (Logan et al., 2002) with homozygous floxed b-cat-nin females [fl; (Huelsken et al., 2001)]. Conditional β-catenin gain-
f-function mutant mice (b-catex3Prx1/+) were generated by inter-
rossing heterozygous Prx1-Cre males with homozygous exon3
loxed β-catenin females (ex3fl; Harada et al., 1999). Mutant em-
ryos were identified by altered morphology, and genotypes were
onfirmed by PCR.
keletal Analysis
mbryos at embryonic day 18.5 or P0 were skinned, eviscerated,
nd fixed in 95% EtOH. Skeletons were stained with alizarin red
nd alcian blue for mineralized and cartilaginous regions, respec-
ively, or only with alcian blue (McLeod, 1980).
lkaline Phosphatase Staining, Histology, In Situ Hybridization
mbyros were dissected, washed in PBS, fixed for 20 min in
%PFA/PBS at 4°C, and incubated for 30 min in PBS at 70°C to
nactivate endogenous alkaline phosphatase, followed by three
ashes of 10 min each in 100 mM NaCl, 100 mM Tris (pH 9.5), 50
M MgCl2, 0.1% Tween 20 and development with BM Purple
Roche). Stained embryos were gelatin embedded and vibratome
ectioned at 15 m. For histology and section in situ hybridization,
mbryos were fixed overnight in 4% PFA/PBS, dehydrated to 100%
tOH, embedded in paraffin, and sectioned at 5 m. Section and
hole-mount in situ hybridizations were done according to Mur-
augh et al. (1999) and Riddle et al. (1993). All probes are available
y request. Hematoxylin/eosin, TRAP, and van Kossa stainings
ere performed by using standard protocols.
rimary Cell Cultures and Adenoviral Transfer
or dissociated humeri/femora cultures, skeletal elements were
issected from limbs of Prx1/− or heterozygous 13.5 dpc em-
ryos. Cells were dissociated in 0.3% Collagenase IV/0.1% Tryp-
in/2% FCS/DMEM for 2 hr at 37°C and plated at 2× 105 cells/well
n a 24-well dish. Cultures were grown in differentiation medium
DMEM-F12, 10% FCS, 5 mM β-glycerophosphate, 100 g/ml
scorbic acid). Recombinant proteins (R&D) were added: rmShh-N
t 300 ng/ml and rhBMP2 at 6 ng/ml. Total RNA for real-time analy-
is was isolated at day 6 by using the Trizol method.
For osteoblast cultures, calvariae were isolated from E16.5 fl/fl
ittermates by avoiding the cartilaginous base. Soft tissue was re-
oved by dissection and incubation in 1% trypsin/EDTA for 10 min
t 37°C. Calvariae were rinsed three times with PBS and subjected
o five sequential digests with 1 ml 2% Collagenase type IS (Sigma)
nd 1% Collagenase/Dispase (Roche) in DMEM-F12 (Invitrogen) for
0 min each at 37°C. The last three digests were collected; debris
as removed by using a cell strainer. Cells were grown for 2 days
n two separate T25 flasks in DMEM-F12/10% FCS or until conflu-
nt. Then, cells were collected, resuspended in 150 l medium,
nd split into three aliquots: two controls (untreated; infected with
deno-EGFP viral supernatant [6 × 107 viral particles/l]), and one
nfected with Adeno-Cre virus (6 × 107 viral particles/l). Cells were
lated into a T25 flask, grown for 2 days (after 24 hr, approximately
0%–95% cells were GFP positive), and collected. The cell number
as determined, and cells were plated at a density of 2 × 105/well
n 6-well plates and at 1 × 105 cells/well for 24-well plates. From the
ollowing day onward (=d0), cells were incubated in differentiation
edium for up to 21 days.
For micromass cultures fore- and hindlimb buds of 11.0–11.5 dpc
omozygous fl or ex3fl embryos were collected, digested with
.1% Collagenase IV, 1% Trypsin, 2% FCS for 15 min, shaken at
7°C, and further dissociated through vigorous pipetting. Cell sus-
ension was placed in DMEM-F12, 10% FCS, and half of the cell
uspension was inoculated with AdGfp (6.5 × 107 viral particles/l),
alf with AdCre (6.5 × 107 viral particles/l) virus, before plating 10
l droplets at 2 × 107 cells/ml in humidified 4-well plates. Cells were
llowed to attach for 75 min and then overlaid with 700 l DMEM-
12, 10% FCS. Medium was changed daily. Recombinant rhBMP4
R&D) was added at 6 ng/ml.
taining of Cultured Cells
or alcian blue staining, micromass cultures were fixed after 4 or 6
ays in culture and processed accordingly (Hartmann and Tabin,
001). In situ hybridizations were done according to the whole-
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737mount protocol, with slight modifications. Alizarin red staining was
done following standard protocols.
RT-PCR Analysis
For RT-PCR and real-time PCR analysis, 1 g total RNA was used
to produce first-strand cDNA. Semiquantative RT-PCR was normal-
ized to mGAPDH expression. Real-time PCR was performed by
using SYBR green 1 nucleic acid gel stain (Molecular Probes) and
TAKARA Taq. Values were calculated by using the comparative C(t)
method and normalized to mTubulin expression. All primer sets
amplified products across exon/intron boundaries; sequences are
available by request.
Western Blot Analysis
For Western blot analysis, protein was extracted from two micro-
mass cultures for each time point. Protein concentration was deter-
mined after Bradford (Biorad). 10 g extract was loaded per lane.
β-catenin (1:250; BD Transduction Laboratories) and tubulin
(1:1000; Sigma) antibodies were used, followed by the appropriate
HRP-conjungated secondary antibodies (1:2500; Promega) and
luminol detection.
Supplemental Data
Supplemental Data showing the skeletal phenotype of the
β-catenin gain-of-function mutants are available at http://www.
developmentalcell.com/cgi/content/full/8/5/727/DC1/.
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